SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-12-010747
Filing Date
2012-03-15
Accepted
2012-03-15 15:21:49
Documents
1
Period of Report
2012-03-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 3366
  Complete submission text file 0001127602-12-010747.txt   4711
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 EUROPA DRIVE STE 170 CHAPEL HILL NC 27514
Business Address
SANDERS CHARLES A (Reporting) CIK: 0001022936 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23186 | Film No.: 12693774